Literature DB >> 615694

Lergotrile mesylate: an in vivo dopamine agonist which blocks dopamine receptors in vitro.

J W Kebabian, D B Calne, P R Kebabian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 615694

Source DB:  PubMed          Journal:  Commun Psychopharmacol        ISSN: 0145-5699


× No keyword cloud information.
  6 in total

1.  Is dopamine-sensitive adenylate cyclase involved in regulating the activity of striatal cholinergic neurons?

Authors:  C Euvrard; J Premont; C Oberlander; J R Boissier; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

Review 2.  Brain dopamine receptors: 20 years of progress.

Authors:  J W Kebabian
Journal:  Neurochem Res       Date:  1993-01       Impact factor: 3.996

3.  Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary.

Authors:  P Onali; J P Schwartz; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

4.  Interaction of pergolide with central dopaminergic receptors.

Authors:  M Goldstein; A Lieberman; J Y Lew; T Asano; M R Rosenfeld; M H Makman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

5.  Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.

Authors:  P F Teychenne; A J Rosin; C N Plotkin; D B Calne
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

6.  Experimental catalepsy is both enhanced and disrupted by apomorphine.

Authors:  W R Klemm
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.